Ticagrelor, which is made by UK firm AstraZeneca and sold under the trade name Brilique, reduces this risk by making clots less likely.
替卡格雷由英国公司阿斯利康 (AstraZeneca) 制造，以倍林达 (Brilique) 为商品名进行销售，可通过减少血栓的形成来降低发病风险。